Physician Assistant in Andover, KS Accepting Medicare

11 Physician Assistant nurses found. Showing 1 - 11

Christopher Ryan Lemons, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 308 E Central Ave, Andover, KS 67002 Phone: 316-993-1774

Emi Hayashi, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1118 E Us Highway 54, Andover, KS 67002 Phone: 316-655-7311

Jill L Johnson-smith, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 612 N Andover Rd, Andover, KS 67002 Phone: 316-733-6618    Fax: 316-733-5299

Mrs. Shala Renee Holman, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1124 W. 21st Street, Andover, KS 67002 Phone: 316-300-4000    Fax: 316-300-4040

Jamie Marie Geier, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 308 E Central Ave, Andover, KS 67002 Phone: 316-733-1331    Fax: 316-677-2747

Mrs. Rachel Ann Ewing, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 105 S Andover Rd, Suite D, Andover, KS 67002 Phone: 316-733-5120    Fax: 316-733-1280

Mckay Alexander Brumfield, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 1731 N Basswood Ct, Andover, KS 67002 Phone: 316-573-3504

Sonja Tuel, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 943 N Andover Rd, Andover, KS 67002 Phone: 316-733-4747

Emily N Regehr, PA Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 105 S Andover Rd, Ste D, Andover, KS 67002 Phone: 316-733-5120    Fax: 316-733-1280

Catherine A Scheve, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 308 E Central, Andover, KS 67002 Phone: 316-733-1331    Fax: 316-733-4916

Mrs. Bridgette K Pocock, PA Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 308 E Central Ave, Andover, KS 67002 Phone: 316-733-1331    Fax: 316-733-6846

News Archive

Shigella dysenteriae pathogen probably originated in Europe, genetic study reveals

The largest genetic study on the bacterium responsible for epidemic dysentery has revealed that the Shigella dysenteriae pathogen, which remains a real scourge in Africa and Asia, probably originated in Europe.

Researchers explain why vertebrate intestines are so predictably loopy

Between conception and birth, the human gut grows more than two meters long, looping and coiling within the tiny abdomen. Within a given species, the developing vertebrate gut always loops into the same formation-however, until now, it has not been clear why.

Mechanical properties of bone revealed through micro-indentation testing

Unravelling the mechanical properties of bone with micro-indentation testing has significance in both health and disease. At the University Medical Center Hamburg-Eppendorf, Dr. Björn Busse and his research group have advanced their micro-indentation testing technique using an Olympus industrial inspection digital light microscope, as an alternative to electron microscopy. The cutting edge research is described in a new application note from Olympus, available online.

DBV Technologies' Viaskin safe and effective in treating children with peanut allergy

DBV Technologies, creator of Viaskin, a new standard in the treatment of allergy, announced today that AP-HP (Assistance Public - Hôpitaux de Paris) sponsor of the ARACHILD study presented at the EAACI Congress a late breaking oral presentation on safety and efficacy data after six months of epicutaneous immunotherapy in peanut allergy using Viaskin Peanut.

Glaxo to pay $750 million settlement for defective, unsafe medicines

The New York Times: "GlaxoSmithKline, the British drug giant, has agreed to pay $750 million to settle criminal and civil complaints that the company for years knowingly sold contaminated baby ointment and an ineffective antidepressant — the latest in a growing number of whistle-blower lawsuits that drug makers have settled with multimillion-dollar fines." The 20 medicines that were produced with "questionable safety" measures included "Avandia, a troubled diabetes drug; Coreg, a heart drug; and Tagamet an acid reflux drug."

Read more Medical News

› Verified 3 days ago